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Summary: This study investigated the prevalence of electrocardiographically determined left ventricular hypertrophy in 
hypertensive and normotensive type 2 diabetic females who went for consultation at the University of Port Harcourt 
Teaching Hospital (UPTH), Rivers State, Nigeria. Two hundred participants mean age 52years, attending the medical 
outpatient clinic over a 6-month period were recruited for the study.  Of the population studied, 16.5% of the hypertensive 
and 13.0% of the normotensive diabetics had left ventricular hypertrophy. Cardiovascular abnormalities notably 
bifascicular block, left atrial block, right ventricular enlargement, and right atrial enlargement were predominately among 
hypertensive diabetes and also notably  was arrhythmia  and atrial flutter among normotensive diabetes. The significance 
of these findings is discussed. 
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It is well established that left ventricular hypertrophy 
(LVH) is of clinical significance as it is an 
independent   cardiovascular (CV) risk factor. And is 
also known  that  diabetes, especially type 2 diabetes 
and raised blood pressure, more specifically, 
hypertension  are among the main risk factors for 
cardiovascular disease (CVD)  (Howard et al 1999; 
Zimmet et al., 2001:  Ciardullo et al  2004;Lozano et 
al 2006).Though left ventricular hypertrophy is a  
powerful predictor of cardiovascular  morbidity and 
mortality , less is known about the prevalence of  left 
ventricular hypertrophy  and its relation to other 
cardiovascular risk factors in hypertensive and 
normotensive diabetes in Africa and in particular 
Nigeria. Studies in the general population (Levy et al. 
1990; Ciardullo et al 2004) and in cohorts of 
hypertensive (Koren et al., 1991) have documented a 
several-fold increase in the risk of cardiovascular 
events in subjects with left ventricular hypertrophy. 
There is evidence from large population based studies 
of an increased tendency to left ventricular 
hypertrophy in hypertensive blacks, independent of 
body composition (Kizer et al., 2004). Data from  
 
population studies demonstrate that women with 
diabetes are at greater risk for cardiovascular disease, 
the leading cause of death among women and an 
independent risk factor for cognitive decline (Coker 
and Shumaker, 2003). However, previous studies 
have demonstrated conflicting results with respect to 
the prevalence of LVH on ECG in individuals with 
and without diabetes Okin et al (2006). Despite the 
growing importance of diabetes mellitus in Nigeria, 
few evidences support the related complications and 
particularly cardiovascular complications (Falase 
1980).  In a review, it has been suggested that 
although considered to be rare; cardiovascular disease 
was on the rise among people with diabetes in 
Nigeria and was regularly associated with classical 
risk factors (Ladipo et al., 1997).  
Thus the objective of this study therefore, was to 
electrocardiographically determine the prevalence of 
left ventricular hypotrophy (LVH) and other related 
cardiovascular abnormalities in hypertensive 
compared to normotensive diabetes females which 
will be of medical interest. 
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MATERIALS AND METHODS 
The study is a prospective hospital-based study 
carried out at the Department of Medicine, University 
of Port Harcourt Teaching Hospital (UPTH) Port 
Harcourt, Nigeria, from January 2009 to June 2009. 
A total of two-hundred (200) female patients, 
consisting of 98 (49%) hypertensive and 102 (51%) 
normotensive diabetes aged 20 to 91 years were 
recruited for the study.  
Ethical Clearance:  
The study design and the protocol were approved by 
the Medical Ethical and Research Committee of the 
University of Port Harcourt Teaching Hospital 
(UPTH) Port Harcourt. Informed consent was 
obtained from each participants employed for the 
study after considerable explanation. 
Electrophysiology: 
 The participants were subjected to physical 
examination and their cardiovascular histories were 
determined from medical records. The diagnosis of 
LVH was assessed electrocardiographically by 
cardiologist using standard 12 lead electrocardiogram 
(ECG) machine based on Minnesota criteria.  
Selection of Subjects: 
The Socio-economic class of the subjects was 
determined by comparing subjects in regular 
employment with those not in regular employments. 
Hypertension was defined according to WHO 
definition as "systolic blood pressure  140 mm Hg, 
and/or diastolic blood pressure  90 mm Hg, and/or 
currently under antihypertensive drug treatment" 
(Chobanian et al.,2003). 
  Diabetes was defined as a fasting blood glucose 
concentration >7.0 mmol/l or as the administration of 
insulin or oral hypoglycaemic drugs. 
Statistical Analysis: 
Data from the standard questionnaire were entered 
into a Microsoft Excel (2000) spreadsheet for 
statistical analysis. Measure of central tendency using 
range, means and median, measure of spread using 
standard deviation and variance were calculated for 
quantitative and qualitative data. Continuous 
variables were expressed as mean ± SD (standard 
deviation) and categorical variables expressed as 
percentages. A p value <0.05 was set as statistically 
significant. The student’s t- test was used as 
appropriate. Correlation analysis was also used as 
appropriate. 
RESULTS 
The mean age of 200 participants was 52 years. The 
age of the hypertensive diabetes was 
52.95±14.21years and was statistically significantly 
higher ( p˂ 0.05) than that of the normotensive  
Table 1: 
Percent characteristics of ECG abnormalities in 


























51(25.5%) 26(13%) 25(12.5%) 
ST elevation + 
T inversion 
42(21%) 21(10.5%) 21(10.5%) 
Left atrial 
deviation 
40(20%) 17(8.5%) 23(11.5%) 
Left atrial 
enlargement 
21(10.5%) 15(7.5%) 6(3%) 




17(8.5%) 11(5.5%) 6(3.3%) 
Prolonged QT 
interval  
16(8%) 9(4.5%) 7(3.5%) 
Left bundle 
branch block 
15 (7.5%) 7(3.5%) 8(4.0%) 
Sinus 
tachycardia 
15(7.5%) 4(2.0%) 11(5.5%) 
Poor R wave 
progression 
14(7.0%) 8(4.0%) 6(3.3%) 
Sinus 
bradycardia 
12(6.0%) 11(5.5%) 1(8.3%) 
Atrial 
fibrillation 
12(6.0% 6(3.3%) 6(3.3%) 
Right atrial 
deviation 
11(5.5%) 7(3.5%) 4(2.0%) 
Right atrial 
enlargement 
9(4.5%) - 9(4.5%) 
First A-V 
block 
8(4.0%) 1(12.5%) 7(3.5%) 
Right bundle 
branch block 
6(3.3%) 3(50%) 3(50%) 
Flattened T 
wave 
6(3.3%) 1(0.5%) 5(2.5%) 
Bifascicular 
block 
4(2.0%) - 4(2.0%) 
Left atrial 
block 




1 - 1(0.5%) 
Arrhythmia 1 1(0.5%) - 
Atrial flutter 1 1(0.5%) - 
diabetes 50.14±14.25 years with variance 202.93 and 
201.91 respectively and Χ2 value=10.133; p=0.1811. 
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Of all participants, 29.5% individuals had a 
documented left ventricular hypertrophy with 
normotensive diabetes 13% and hypertensive diabetes 
16.5% respectively.  The characteristics of 
cardiovascular abnormalities recorded in 
normotensive compared to hypertensive diabetes are 
described in Table 1. 
Most of the ECG abnormalities were significantly 
worse for hypertensive diabetes individuals when 
compared with normotensive diabetes.  
There was an association between the age of the 
participants and ECG characteristics in normotensive 
and hypertensive diabetes females. Using Pearson’s 
correlation coefficient analysis, significant positive 
correlation (p<0.05) were obtained for Age: QRS 
voltage(X² = 0.0959) in normotensive diabetes while 
for the hypertensive diabetes significant positive 
correlations were found for Age: QRS axis (X² 
=0.2786), Age: QT interval (X²=0.2045), Age: QTCB 
interval (X² =0.2126), Age: RR interval (X² =0.2179), 
Age: PP interval (X² =0.2198) 
DISCUSSION 
Certain chronic diseases, especially heart disease, are 
often viewed as primarily affecting men. However, 
chronic diseases, including heart disease, according 
to WHO, affect women and men almost equally. A 
projected global coronary heart disease death by sex, 
for all ages, by the year 2005 was women 47% and 
men 53% (WHO, 2002).  The present study attempts 
mainly to describe and document the complications in 
a cohort of susceptible ECG changes in hypertensive 
diabetes compared to normotensive diabetes females. 
Evidence to support the related complications and 
particularly the cardiovascular complication of 
diabetes and/or hypertension amongst Nigerians are 
still relatively few and not well documented (Falase 
1980). Recently it has been suggested that although 
initially thought to be rare, cardiovascular disease 
(CVD) and associated complications was on the rise 
among Nigerians with diabetes and is regularly 
associated with other classical risk factors (Ladipo et 
al.,1997) nonetheless, these risk factors and the 
associated complications have yet to be fully 
described.  
Our study demonstrated the presence of left 
ventricular hypertrophy on ECG among both 
hypertensive and normotensive diabetes and 
conforms with the previous suggestions that the 
diagnosis of left ventricular hypertrophy on ECG is 
associated with a high cardiovascular risk (Ciardullo  
et al., 2004). The diagnosis of LVH in both 
hypertensive and normotensive diabetes as observed 
in this study might perhaps be a reflection of 
environmental –associated fat inducing increases in 
diabetes as well as in individuals with heart diseases. 
Furthermore, our studies showed that the body mass 
index (kg/m2) of the normotensive and hypertensive 
diabetes 25.90±3.60 and 26.17±3.47 respectively 
were above normal  and were also not statistically 
significantly different (p= 0.219) an indication that 
the  participants were obsess.  In a study, both the 
ratio of total to HDL cholesterol and the non-HDL 
cholesterol were significantly higher in ‘LVH’ 
individuals than in the ‘non-LVH’ cases (Ciardullo et 
al., 2004). Hypertensive diabetes has higher 
prevalence and greater severity of left ventricular 
hypertrophy than those without diabetes ( Bella et al., 
2001,  Palmieri et al., 2001).  
Studies have shown that both hypertension and left 
ventricular hypertrophy are associated with increased 
risk for cardiac arrhythmias (Koren et al., 1991) and 
this study has also confirmed that the majority of the 
hypertensive diabetes had common co- morbid 
conditions. 
Though the present study was conducted exclusively 
on females the findings are consistent with similar 
findings in the Framingham study that the presence of 
LVH on ECG was not a consistent feature in male 
hypertensive diabetes compared to female 
hypertensive diabetes (Kannel and Cobb 1992) or 
with the general population (Ciardullo  et al 2004).  
In conclusion, both hypertensive and normotensive 
diabetes are at higher risk to developing 
cardiovascular disease complications and perhaps this 
might be a reflection of environmental – associated 
increases in body fat which may perhaps require 
further investigations. The observed prevalence in 
LVH on ECG among normotensive and hypertensive 
diabetes, together with the greater prevalence of LVH 
in the Nigerian population studied, might contribute 
to the understanding of the development of an 
increase in high risk of cardiovascular (CV) events 
with aging in women. 
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